DexCom, Inc. (NASDAQ:DXCM) Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ET
Company Participants
Sean Christensen – Vice President of Finance and Investor Relations
Kevin Sayer – Chairman, President and Chief Executive Officer
Jereme Sylvain – Chief Financial Officer
Jake Leach – Chief Operating Officer
Conference Call Participants
Larry Biegelsen – Wells Fargo
Jeff Johnson – Baird
Robbie Marcus – J.P. Morgan
Danielle Antalffy – UBS
Travis Steed – Bank of America
Joanne Wuensch – Citibank
Matt Taylor – Jefferies
Matthew O’Brien – Piper Sandler
Jayson Bedford – Raymond James
Shagun Singh – RBC Capital Markets
Chris Pasquale – Nephron Research
Steve Lichtman – Oppenheimer
Issie Kirby – Redburn-Atlantic
Michael Polark – Wolfe Research
Patrick Wood – Morgan Stanley
Sam Eiber – BTIG
Mike Kratky – Leerink
Operator
Thank you for standing by. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Dexcom Inc. Fourth Quarter 2024 Earnings Release Conference Call.
All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.
I would now like to turn the call over to Sean Christensen, VP of Finance and Investor Relations. Please go ahead.
Sean Christensen
Thank you, Abby, and welcome to Dexcom’s fourth quarter and fiscal year 2024 earnings call.
Our agenda begins with Kevin Sayer, Dexcom’s Chairman, President and CEO, who will summarize our recent highlights and ongoing strategic initiatives, followed by a financial review and outlook from Jereme Sylvain, our Chief Financial Officer.
Following our prepared remarks, we will open the call up for your questions. At that time, we ask analysts to limit themselves to one question each so we can provide an opportunity for everyone participating today. Please note
Read the full article here